Interventional radiology for hepatocellular carcinoma

Minerva Gastroenterologica e Dietologica

Volumn 57, Issue 3, 2011, Pages 299-309

  Loffroy, R ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Ablation techniques; Carcinoma, hepatocellular; Chemoembolization, therapeutic

Indexed keywords

ACETIC ACID; ALBUMIN; ALCOHOL; ALPHA FETOPROTEIN; BILIRUBIN; BIOMATERIAL; CYTOTOXIC AGENT; DOXORUBICIN; IODINATED POPPYSEED OIL; IODINE 131; MICROSPHERE; POLYVINYL ALCOHOL; YTTRIUM 90;

ABLATION THERAPY; ARTIFICIAL EMBOLISM; BILIRUBIN TOXICITY; BLAND EMBOLIZATION; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHEMOEMBOLIZATION; CHOLANGIOGRAPHY; COMORBIDITY; CRYOABLATION; DISEASE PREDISPOSITION; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; FATIGUE; HEPATITIS C; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYDROGEL; INTERVENTIONAL RADIOLOGY; ISOTOPE LABELING; LASER COAGULATION; LASER THERMOTHERAPY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LUNG EMBOLISM; LUNG METASTASIS; MORTALITY; NAUSEA AND VOMITING; PAIN; RADIATION DOSE; RADIATION EXPOSURE; RADIOEMBOLIZATION; RADIOFREQUENCY ABLATION; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; TOXICITY; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CRYOSURGERY; EVIDENCE-BASED MEDICINE; HUMANS; INFUSIONS, INTRA-ARTERIAL; IODINE RADIOISOTOPES; LIVER NEOPLASMS; RADIOLOGY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; YTTRIUM RADIOISOTOPES;

EID: 80755171333     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology 2002;181:35-8. (Pubitemid 36015669)
2. Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 1980;45:2663-9.
3. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995;221:291-8.
4. Alsowmely AM, Hodgson HJ. Non-surgical treatmentof hepatocellular carcinoma. Aliment Pharmacol Ther 2002;16:1-15.
5. Otto G, Heuschen U, Hofman WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. Ann Surg 1998;227:424-32. (Pubitemid 28131024)
6. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-40.
7. Dyon D, Mouzon A, Jourde AN, Regensberg C, Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours. Ann Radiol 1974;17:593-603.
8. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-42. (Pubitemid 36152543)
9. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M et al. Hepatocellular carcinoma: treatment with intra-arterial iodized oil with and without chemotherapeutic agents. Radiology 1987;163:345-51. (Pubitemid 17068905)
10. Sumie S, Yamashita F, Ando E, Tanaka M, Yano Y, Fukumori K et al. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. AJR Am J Roentgenol 2003;181:1327-34. (Pubitemid 37296411)
11. Un SC, Shih SC, Kao CR, Chou SY. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J Gastroenterol 2003;9:1208-11.
12. No authors listed. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Group d'Etude et de Traitment du Carcinome Hepatocellular. N Engl J Med 1995;332:1256-61.
13. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734-9. (Pubitemid 34607087)
14. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71. (Pubitemid 34454013)
15. Uraki J, Yamakado K, Nakatsuka A, Takeda K. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol 2004;51:12-8. (Pubitemid 38746891)
16. Brown KT, Nevins AB, Getrajdman GI, Brody LA, Kurtz RC, Fong Y et al. Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 1998;9:822-8. (Pubitemid 28427845)
17. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology 2002;224:47-54. (Pubitemid 34680374)
18. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-83. (Pubitemid 28264682)
19. Maluccio MA, Covey AM, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI et al. Treatment of metastatic sarcoma to the liver with bland embolization. Cancer 2006;107:1617-23. (Pubitemid 44546923)
20. Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 2006;17:1335-43. (Pubitemid 44259017)
21. Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL et al. Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006;17:335-42. (Pubitemid 44341453)
22. Tang Y, Taylor RR, Gonzalez MV, Lewis AL, Stratford PW. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Control Release 2006:116:e55-6.
23. Taylor RR, Tang Y, Gonzalez MV, Stratford PW, Lewis AL. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 2007;30:7-14. (Pubitemid 44908921)
24. Lewis AL, Gonzalez MV, Leppard SW, Brown JE, Stratford PW, Phillips GJ et al. Doxorubicin eluting beads: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med 2007;18:1691-9. (Pubitemid 47224923)
25. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004;139:766-74. (Pubitemid 38886514)
26. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-7.
27. Llovet JM. Treatment of hepatocellular carcinoma. Curr Treat Options Gastroenterol 2004;7:431-41. (Pubitemid 39585737)
28. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461-9. (Pubitemid 44142456)
29. Livraghi T, Meloni F, Morabito A, Vettori C. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 2004;10:S98-106.
30. de Luis E, Bilbao J, de Ciercoles J, Martinez-Cuesta A, de Martino Rodriguez A, Lozano MD. In vivo evaluation of a new embolic spherical particle (HepaSphere) in a kidney animal model. Cardiovasc Intervent Radiol 2008;31:367-76.
31. Guan YS, Liu Y. Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006;5:495-500. (Pubitemid 44782085)
32. Liapi E, Geschwind JF. Intra-arterial therapies for hepatocellular carcinoma: where do we stand? Ann Surg Oncol 2010;17:1234-46.
33. Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI et al. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis. Aliment Pharmacol Ther 2009;29:1291-8.
34. Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 2006;94:572-86. (Pubitemid 44851918)
35. Carr BI. Hepatic arterial 90-yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004;10:S107-10. (Pubitemid 38240109)
36. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M et al. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004;15:335-45. (Pubitemid 38451976)
37. Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010;138:52-64.
38. Tancredi T, McCuskey PA, Kan Z, Wallace S. Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents. Radiology 1999;211:177-81. (Pubitemid 29161748)
39. Geschwind JF, Artemov D, Abraham S, Omdal D, Huncharek MS, McGee C et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000;11:1245-55.
40. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8. (Pubitemid 23141242)
41. Lencioni R, Bartolozzi C, Caramella D, Paolicchi A, Carrai M, Maltinti G et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: analysis of prognostic factors in 105 Western patients. Cancer 1995;76:1737-46.
42. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
43. Hasegawa S, Yamasaki N, Hiwaki T, Sako K, Komorizono Y, Baba Y et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999;86:1682-90. (Pubitemid 29513036)
44. Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000;88:529-37. (Pubitemid 30056925)
45. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30. (Pubitemid 41002049)
46. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004;127:1714-23.
47. Lencioni RA, Allgaler HP, Cloni D, Olschewski M, Deibert P, Crocetti L et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-40. (Pubitemid 36736097)
48. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009;49:453-9.
49. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation versus percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009;104:514-24.
50. Ohnishi K, Ohyama N, Ito S, Fujiwara K. Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 1994;193:747-52. (Pubitemid 24366946)
51. Ohnishi K. Comparison of percutaneous acetic acid injection and percutansous ethanol injection for small hepatocellular carcinoma. Hepatogastroenterology 1998;45:1254-8. (Pubitemid 28372109)
52. Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY et al. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol 2003;14:1648-53.
53. Georgiades CS, Hong K, Geschwind JF. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 2008;14:117-22.
54. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg 2002;194:813-28. (Pubitemid 34633646)
55. Yokoyama T, Egami K, Miyamoto M, Watanabe H, Hasegawa H, Iida S et al. Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg 2003;10:425-7. (Pubitemid 38128791)
56. Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C, Tasselli S et al. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg 2007;11:143-9.
57. Arch-Ferrer JE, Smith JK, Bynon S, Eckhoff DE, Sellers MT, Bland KI et al. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. Am Surg 2003;69:1067-71. (Pubitemid 44296668)
58. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg 2002;194:813-28. (Pubitemid 34633646)
59. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-8. (Pubitemid 30115377)
60. Camma C, Di Marco V, Orlando A, Sandonato L, Casaril A, Parisi P et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 2005;42:535-40. (Pubitemid 40342933)
61. Crucitti A, Danza FM, Antinori A, Vincenzo A, Pirulli PG, Bock E et al. Radiofrequency thermal ablation (RFA) of liver tumors: percutaneous and open surgical approaches. J Exp Clin Cancer Res 2003;22:191-5. (Pubitemid 38436456)
62. Georgiades CS, Hong K, Geschwind JF. Pre- and postoperative clinical care of patients undergoing interventional oncology procedures: a comprehensive approach to preventing and mitigating complications. Tech Vasc Interv Radiol 2006;9:113-24. (Pubitemid 46875014)
63. Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ et al. Hepatocellular carcinoma: US guided percutaneous microwave coagulation therapy. Radiology 2001;221:167-72. (Pubitemid 32880384)
64. Yamashiki N, Kato T, Bejarano PA, Berho M, Montalvo B, Shebert RT et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol 2003;98:2052-9. (Pubitemid 37185805)
65. Yu NC, Lu DS, Raman SS, Dupuy DE, Simon CJ, Lassman C et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters - pilot comparison with pathologic findings. Radiology 2006;239:269-75.
66. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694-702. (Pubitemid 29169669)
67. Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003;180:1547-41.
68. Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299-307. (Pubitemid 40432267)
69. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331-7. (Pubitemid 34454307)
70. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 2007;25:978-86. (Pubitemid 350002864)
71. Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: Results in 74 patients. Radiology 2001;221:712-20. (Pubitemid 33101763)
72. Guo Z, Xin WG, Uu F, Yu HP, Li BG, Guo XY et al. Clinical application of Argon-helium cryotherapy system in the treatment of hepatocellular carcinoma. Chin J Radiol 2005;39:198-203.
73. Wu F, Wang Z, Chen W. Pathological study of extracorporeally ablated hepatocellular carcinoma with high-intensity focused ultrasound. Zhonghua Zhong Liu Za Zhi 2001;23:237-9.
74. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheteer arterial embolization. Radiology 2005;235:659-67. (Pubitemid 40571111)
75. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 2008;299:1669-77. (Pubitemid 351519864)
76. Kurokohchi K, Hosomi N, Yoshitake A, Ohgi T, Ono M, Maeta T et al. Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation. Oncol Rep 2006;16:1067-70.
77. Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B et al. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with nonresectable hepatocellular carcinoma. World J Gastroenterol 2006;12:3707-15. (Pubitemid 43950948)